alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1**

 

**CERTIFICATION**

 

I, Brett D. Davis, certify that:

 

1.             I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of CNH Equipment Trust 2015-B (the “Exchange Act periodic reports”);

 

2.             Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.             Based on my knowledge, all of the distribution, servicing and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

 

4.             I am responsible for reviewing the activities performed by the servicer and based on my knowledge and the compliance review conducted in preparing the servicer compliance statement required in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicer has fulfilled its obligations under the servicing agreement in all material respects; and

 

5.             All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10-K.

 

In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated parties: Deutsche Bank Trust Company Americas.

 

----

 

March 29, 2016

 
|   | By:    | /s/ Brett D. Davis                                               |
|--------|--------|------------------------------------------------------------------|
|   | Name:  | Brett D. Davis                                                   |
|   | Title: | President (senior   officer in charge of the servicing function) |

 

----
### I N THE UNI TED STATES COURT OF APPEALS FOR THE FI F TH CI RCUI T

No. 12-31199 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee

v. NAESHA C. LOW, Defendant-Appellant

A ppeal from the United States District Court for the Western District of Louisiana USDC No. 5:12-CR-92-6

Before JOLLY, JONES, and HIGGINSON, Circuit Judges. PER CURIAM: * The attorney appointed to represent Naesha C

. Low has moved for leave to withdraw and has filed a brief in accordance with Anders v. C a l i f o r n i a , 386 U.S. 738 (1967), a nd U nited States v. Flores , 632 F.3d 229 (5th Cir. 2011). Low has n ot filed a response. We have reviewed couns e l ’ s brief and the relevant portions of the record r e flected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. U n i t e d S t a te s C o u r t o f A p p e al s

F i f t h C i rc u i t 

### F I L E D October 25, 2013 Ly l e W . Cay ce Clerk

* Purs uant to 5 T H C I R

. R

. 47. 5, the court has d eterm ined that this op inion should not be p ublis hed and is not p reced ent excep t und er the lim ited circum s tances s et forth in 5 T H C I R

. R. 47. 5. 4. Case: 12-31199 Document: 00512419921 Page: 1 Date Filed: 10/25/2013No. 12-31199

The record d oes r eveal a clerical error i n the judgment. The judgment should b e corrected to refle c t t h a t Low pleaded guilty t o and was convicted of conspira c y to possess with the intent to distribute methamphetamine in violation of 21 U.S.C. §§ 841(a)(1), 846. See F E D
. R. C R I M
. P. 36. Accordingly, counsel’s motion for leave to withdraw i s G RANTED, counsel is excused from fu r t h e r responsibilities h erein, and the APPEAL IS DISMISSED. S ee 5 T H C I R
. R. 42.2. The case is R E MANDED f or c o r r e c t i on of the clerical error pursuant to Federal Rule of Criminal Procedure 36.

2 Case: 12-31199 Document: 00512419921 Page: 2 Date Filed: 10/25/2013
V. B., A CHILD,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D15-2543

_____________________________/

Opinion filed November 13, 2015.

An appeal from the Circuit Court for Leon County.

Charles W. Dodson, Judge.

Nancy A. Daniels, Public Defender, and Archie F. Gardner, Jr., Assistant Public 

Defender, Tallahassee, for Appellant.

Pamela Jo Bondi, Attorney General, Quentin Humphrey, Assistant Attorney 

General, and Trisha Meggs Pate, Bureau Chief, Criminal Appeals, Tallahassee, for 

Appellee.

PER CURIAM.

AFFIRMED.

WOLF, WETHERELL, and MARSTILLER, JJ., CONCUR.
IA

103D CONGRESS

1ST SESSION H. J. RES. 85

Designating March 1, 1993, through March 5, 1993, as ‘‘National

Saleswoman Week’’.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 2, 1993

Mrs. JOHNSON of Connecticut introduced the following joint resolution; which

was referred to the Committee on Post Office and Civil Service

JOINT RESOLUTION

Designating March 1, 1993, through March 5, 1993, as

‘‘National Saleswoman Week’’.

Whereas half of all sales positions are filled by women, including over two-thirds of the retail sales force;

Whereas veteran saleswomen can teach new saleswomen effective strategies for successful careers;

Whereas the average earnings of saleswomen increased by 43

percent between 1983 and 1990;

Whereas there are associations which help saleswomen network, learn sales skills, share ideas, take advantage of

job banks, and offer support to each other; and
2

HJ 85 IH

Whereas local chapters of such associations regularly hold

seminars, workshops, and meetings to further the professional lives of women already in sales and marketing and

those considering such careers: Now, therefore, be it

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled,

3 That March 1, 1993, through March 5, 1993, is des4 ignated as ‘‘National Saleswoman Week’’. The President

5 is authorized and requested to issue a proclamation calling

6 upon the people of the United States to observe such week

7 with appropriate ceremonies and activities.

Æ
Page 1 of 1

TTB 3.1 Table

$000,000s

Agency External Agency External Total Agency External Agency External Total Agency External Agency External Total Percent

Capital Investments Total 10.717 - 16.676 - 27.393 7.571 - 16.520 - 24.091 4.636 - 17.188 - 21.824 -9%

Major IT sub-total

non-Major IT sub-total 10.717 - 16.176 - 26.893 7.571 - 15.740 - 23.311 4.636 - 16.588 - 21.224 -9%

IT Total 10.717 - 16.176 - 26.893 7.571 - 15.740 - 23.311 4.636 - 16.588 - 21.224 -9%

non-IT Total - - 0.500 - 0.500 - - 0.780 - 0.780 - - 0.600 - 0.600 -23%

TTB Major IT Investments

TTB non-Major IT Investments

TTB General Support Services - - 2.947 - 2.947 - - 3.537 - 3.537 - - 2.470 - 2.470 -30%

015-13-1008-0 TTB Salary and Expense - - 2.947 - 2.947 - - 3.537 - 3.537 - - 2.470 - 2.470 -30%

TTB IT Infrastructure End User Systems and Support 

(ITI EUSS)

- - 3.698 - 3.698 - - 3.227 - 3.227 - - 3.836 - 3.836 19%

015-05-1881 Community Development Financial 

Institutions Fund Program Account

- - 0.869 - 0.869 - - 1.381 - 1.381 - - 1.395 - 1.395 1%

015-13-1008-0 TTB Salary and Expense - - 2.829 - 2.829 - - 1.847 - 1.847 - - 2.441 - 2.441 32%

TTB IT Infrastructure Mainframes and Servers 

Services and Support (ITI MSSS)

- - 5.416 - 5.416 - - 4.181 - 4.181 - - 4.482 - 4.482 7%

015-05-1881 Community Development Financial 

Institutions Fund Program Account

- - 0.714 - 0.714 - - 0.628 - 0.628 - - 0.408 - 0.408 -35%

015-13-1008-0 TTB Salary and Expense - - 4.702 - 4.702 - - 3.553 - 3.553 - - 4.074 - 4.074 15%

TTB IT Infrastructure Telecommunications (ITT TSS) - - 3.101 - 3.101 - - 3.779 - 3.779 - - 4.864 - 4.864 29%

015-05-1881 Community Development Financial 

Institutions Fund Program Account

- - 0.135 - 0.135 - - 0.478 - 0.478 - - 0.682 - 0.682 43%

015-13-1008-0 TTB Salary and Expense - - 2.966 - 2.966 - - 3.301 - 3.301 - - 4.182 - 4.182 27%

TTB IT Management - - 1.013 - 1.013 - - 1.016 - 1.016 - - 0.936 - 0.936 -8%

015-13-1008-0 TTB Salary and Expense - - 1.013 - 1.013 - - 1.016 - 1.016 - - 0.936 - 0.936 -8%

TTB Regulatory System 7.110 - - - 7.110 4.582 - - - 4.582 2.783 - - - 2.783 -39%

015-13-1008-0 TTB Salary and Expense 7.110 - - - 7.110 4.582 - - - 4.582 2.783 - - - 2.783 -39%

TTB Tax System 3.607 - - - 3.607 2.989 - - - 2.989 1.853 - - - 1.853 -38%

015-13-1008-0 TTB Salary and Expense 3.607 - - - 3.607 2.989 - - - 2.989 1.853 - - - 1.853 -38%

TTB non-IT Investments

TTB Scientific Equipment Refresh - - 0.500 - 0.500 - - 0.780 - 0.780 - - 0.600 - 0.600 -23%

015-13-1008-0 TTB Salary and Expense - - 0.500 - 0.500 - - 0.780 - 0.780 - - 0.600 - 0.600 -23%

PY 2016 Funding (Actual) CY 2017 Funding (Enacted) BY 2018 Funding (Estimated) 

DME O&M Total DME O&M Total DME O&M Total

Change 

from CY 

to BY
#### SERVICE FINANCE CORPORATION et al. v. GROTE.

*No.*11056.

Court of Civil Appeals of Texas. San Antonio.

July 7, 1943.

R. R. Smith, of Jourdanton, and Harry J. Polk, of Corpus Christi, for appellants.

Pichinson & Alsup and M. V. Carson, Jr., both of Corpus Christi, for appellee.

SMITH, Chief Justice.

This cause was instituted in a District Court of Nueces County. In due course appellant J. C. Minus filed his plea of privilege to be sued in the county of his residence, to-wit: Bexar County. The trial court overruled said plea of privilege and Minus appealed from that order to this Court. Subsequently that appeal was transferred upon order of our Supreme Court to the Court of Civil Appeals of the Eighth District at El Paso. The 'latter Court ordered reversal of the judgment overruling Minus’ plea of privilege and transfer of the cause to any District Court of Bexar County. Minus v. Grote, Tex.Civ.App., 154 S.W.2d 140, Grote v. Price, 139 Tex. 472, 163 S.W.2d 1059.

In the meantime, however, and pending that appeal from the order overruling Minus’ plea of privilege, the cause was tried in the court below on the merits and judgment was rendered there in favor of Grote against appellants, who brought this appeal therisfrom. The parties now present their joint motion that the judgment on the merits be reversed and the cause remanded to the court below with instructions to transfer the cause to the District Court of Bexar County in accordance with the order of the El Paso Court of Civil Appeals. The motion is granted.

“It having been determined * * * on the first appeal that appellant’s plea of privilege was well taken and should have been sustained by the trial court, that court was without jurisdiction to hear and determine the cause on its merits.” Wilson v. Ryan, Tex.Civ.App., 163 S.W.2d 448.

Accordingly, the judgment of the trial court in this case will be reversed and the cause remanded, with instructions to the Clerk of the District Court of Nueces County, if he has not already done so, to make up a transcript of all the orders made in said cause prior to and including the order overruling appellant’s plea of privi-' lege, certifying thereto officially, under the seal of the court, and send it with the original papers in the cause to the Clerk of the District Courts of Bexar County, as originally ordered by the El Paso Court of Civil Appeals.

Reversed and remanded, with instructions.
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO SECTION 906OF THESARBANES-OXLEY ACT OF 2002**

Pursuantto section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) ofsection 1350, chapter 63 of Title 18, United States Code), the undersignedofficer of NEOPHARM, Inc., a Delaware corporation (the “Company”), does herebycertify with respect to the Quarterly Report of the Company on Form 10-Q forthe quarter ended March 31, 2007 as filed with the Securities and ExchangeCommission (the “10-Q Report”) that:

(1)                                  the10-Q Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

(2)                                  theinformation contained in the 10-Q Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.
| Dated: May 10, 2007 | /s/ Laurence P. Birch                                                                                                                  |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------|
|                | Laurence P. Birch                                                                                                                      |
|                | President and Chief Executive  Officer (Principal Executive Officer) and Acting Chief Financial Officer  (Principal Financial Officer) |

 

----
1

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

FORT WORTH DIVISION

Chasity Congious, by and through )

her Guardian, Kimberly Hammond, )

on behalf of herself and as Mother and )

Next Friend of Z.C.H., Deceased, )

)

Plaintiff, )

)

v. ) Case No. 4:22-cv-00092-O 

)

City of Fort Worth, et al., )

)

Defendants. )

PLAINTIFF AND TARRANT COUNTY’S MEDIATION REPORT

Pursuant to the Court’s Amended Scheduling Order (ECF No. 65, Part II, Section 

5(c)), the parties respectfully submit the following mediation report. 

The mediation was conducted on December 4, 2023. The persons present for the 

mediation were: 

1. Mediator M. Beth Krugler, JD MS

2. For Plaintiff: Kimberly Hammond, Attorney Jarrett Adams, and Attorney 

Arielle Comer

3. For Defendant Tarrant County: Assistant Criminal District Attorneys M. 

Keith Ogle and Katherine E. Owens; Tarrant County Assistant Director of 

Risk Management Travis Yarbrough; and Tarrant County Sheriff’s Office 

Senior Chief Calvin Bond

The mediation on December 4, 2023 did not resolve this case by settlement of the 

parties. Following the mediation, the mediator sent the parties a settlement proposal. 

Case 4:22-cv-00092-O Document 84 Filed 12/11/23 Page 1 of 3 PageID 990
2

The parties have until December 20, 2023 at 2:00 PM CST to accept or reject the 

proposal. 

Respectfully submitted,

Chasity Congious, by and through her Next 

Friend, Kimberly Hammond, on behalf of 

herself and as Mother of Z.C.H., deceased,

/s/ Jarrett Adams

Jarrett Adams

LAW OFFICES OF JARRETT ADAMS, PLLC

40 Fulton St., Floor 28

New York, New York 10038

T: 646.880.9707

F: 646.880.9707

E: JAdams@JarrettAdamsLaw.com

and

/s/ M. Keith Ogle

M. KEITH OGLE

State Bar No. 24037207

Assistant Criminal District Attorney

PHIL SORRELLS

CRIMINAL DISTRICT ATTORNEY

TARRANT COUNTY, TEXAS

Tarrant County Criminal District Attorney’s 

Office

Tim Curry Criminal Justice Center

401 W. Belknap, 9th Floor

Fort Worth, Texas 76196

817-884-1233 - Telephone

817-884-1675 – Facsimile

E-Mail: mkogle@tarrantcountytx.gov

ATTORNEY FOR DEFENDANT

TARRANT COUNTY

Case 4:22-cv-00092-O Document 84 Filed 12/11/23 Page 2 of 3 PageID 991
3

CERTIFICATE OF SERVICE

I hereby certify that on December 11, 2023, I electronically filed the foregoing 

pleading with the United States District Court for the Northern District of Texas using 

the CM/ECF system, which will automatically serve a true and complete copy upon all 

counsel of record. 

/s/Jarrett Adams

Jarrett Adams, Esq.

Case 4:22-cv-00092-O Document 84 Filed 12/11/23 Page 3 of 3 PageID 992
**Exhibit 32.2**

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18,

 

UNITED STATES CODE)

 

Pursuant tosection 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) ofsection 1350, chapter 63 of Title 18, United States Code), the undersignedofficer of NeoPharm, Inc., a Delaware corporation (the “Company”), does herebycertify with respect to the Quarterly Report of the Company on Form 10-Q forthe quarter ended June 30, 2003 as filed with the Securities and ExchangeCommission (the “10-Q Report”) that:

 

(1)               the10-Q Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2)               theinformation contained in the 10-Q Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.

 

 
| Dated:  August 14, 2003 | /s/ Lawrence  A. Kenyon  |   |
|------------------------------|--------------------------|--------|
|                         | Lawrence A.  Kenyon,     |
|                         | Chief  Financial Officer |

 

----
[Federal Register Volume 65, Number 219 (Monday, November 13, 2000)]
[Notices]
[Page 67788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-29047]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE


Notice of Meeting of the Industry Sector Advisory Committee on 
Services (ISAC-13)

AGENCY: Office of the United States Trade Representative.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: The Industry Sector Advisory Committee on Services will hold a 
meeting on November 21, 2000, from 9:00 a.m. to 12:30 p.m. The meeting 
will be opened to the public from 9:00 a.m. to 10:00 a.m., and closed 
to the public from 10:00 a.m. to 12:30 p.m.

DATES: The meeting is scheduled for November 21, 2000, unless otherwise 
notified.

ADDRESSES: The meeting will be held at the Department of Commerce, 
Conference Room B841-A, located at 14th Street between Pennsylvania and 
Constitution Avenues, NW., Washington, DC.

FOR FURTHER INFORMATION CONTACT: Karen Holderman, (202) 482-0345, 
Department of Commerce, 14th Street and Constitution Avenue, NW., 
Washington, DC 20230, or Dominic Bianchi, Office of the United States 
Trade Representative, 1724 F Street, NW., Washington, DC 20508, (202) 
395-6120.

SUPPLEMENTARY INFORMATION: During the opened portion of the meeting the 
following topics will be discussed:
    1. Review of ISAC Mission to Geneva.
    2. Overview of GATS Work Program.
    3. Review of Preparation of GATS Council for Trade in Services 
Meeting December 6, 2000.

Dominic Bianchi,
Acting Assistant United States Trade Representative for 
Intergovernmental Affairs and Public Liaison.
[FR Doc. 00-29047 Filed 11-8-00; 1:56 pm]
BILLING CODE 3190-01-M
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          56,596
<SECURITIES>                                         0
<RECEIVABLES>                                  964,877
<ALLOWANCES>                                     4,783
<INVENTORY>                                    684,254
<CURRENT-ASSETS>                             1,868,108
<PP&E>                                       6,597,894
<DEPRECIATION>                               1,646,840
<TOTAL-ASSETS>                               7,062,989
<CURRENT-LIABILITIES>                        1,557,106
<BONDS>                                      1,665,880
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     3,797,442
<OTHER-SE>                                     700,802
<TOTAL-LIABILITY-AND-EQUITY>                 7,062,989
<SALES>                                      5,249,377
<TOTAL-REVENUES>                             5,249,377
<CGS>                                        3,197,187
<TOTAL-COSTS>                                3,197,187
<OTHER-EXPENSES>                             1,376,638
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              85,432
<INCOME-PRETAX>                                599,444
<INCOME-TAX>                                   206,686
<INCOME-CONTINUING>                            392,758
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   392,758
<EPS-PRIMARY>                                     0.18
<EPS-DILUTED>                                     0.18
        


</TABLE>
Exhibit 10.3(E)

 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been requested with respect to the omitted portions.

 

CONFIDENTIAL

 

January 9, 2014

 

Marina Biotech, Inc.

3830 Monte Villa Parkway

Bothell, Washington, 98021

Attn: Michael French, Chief executive Officer

 

Re:                             Agreement re Option Compound and miR-34 Sequences

 

Dear Michael:

 

As you know, Mirna Therapeutics, Inc. (“MirnaRx”) and Marina Biotech, Inc. (“Marina Bio”) have entered into an amendment, effective as December 27, 2013, to that certain license agreement dated December 22, 2011 (the “License Agreement”, and such amendment the “Amendment”).  This letter agreement is that certain Amendment Side Letter referred to in the Amendment, and it sets forth the RNA oligonucleotide sequences of the Option Compounds that the Parties are agreeing to designate as Selected MirnaRx Compounds pursuant to the terms of the License Agreement.  Capitalized terms not defined in this Amendment Side Letter shall have the meaning given to those terms in the License Agreement.

 

The Parties hereby agree that the list of RNA oligonucleotide sequences attached as the Appendix of this Amendment Side Letter comprises sequences of miR-34, let-7, miR-25, [***] as well as the sequences of two Option Compounds [***] under the terms of the License Agreement.  The Parties further agree that such sequences are the highly confidential information of MirnaRx, and Marina Bio shall comply with the confidentiality obligations set forth in the License Agreement with respect thereto, and shall not disclose such sequences to any third party or use them for any purpose outside of the License Agreement.

 

	
AGREED TO BY:
    	
Mirna   Therapeutics, Inc.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Signature:
    	
/s/   Paul Lammers
    
	
 
    	
 
    	
Paul   Lammers, M,D., M.Sc.
    
	
 
    	
 
    	
Chief   Executive Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Marina   Biotech, Inc.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Signature:
    	
/s/   Michael French
    
	
 
    	
 
    	
Michael   French
    
	
 
    	
 
    	
Chief   Executive Officer
    


 











 

CONFIDENTIAL

 

APPENDIX

 

miR-34 Sequence:

[***]

 

[***]

 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been requested with respect to the omitted portions.
Case 3:22-cr-00175-M Document 25 Filed 09/12/23 Page 1 of 1 PageID 42
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 1 of 7 PageID 5
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 2 of 7 PageID 6
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 3 of 7 PageID 7
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 4 of 7 PageID 8
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 5 of 7 PageID 9
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 6 of 7 PageID 10
Case 3:22-cv-02174-K-BT Document 3 Filed 09/30/22 Page 7 of 7 PageID 11